Trademarkia Logo

Canada

C$
Trademark Search in Canada
ENTOURAGE

View On IC.GC.CA

ENTOURAGE
REGISTERED

on 14 Oct 2020

Last Applicant/ Owned by

ENTOURAGE INDÚSTRIA E COMÉRCIO LTDA

111 - 11th Floor Rue Tabapuã Itaim BibiSão Paulo

BR

Serial Number

1747294 filed on 23rd Sept 2015

Registration Number

TMA1084812 registered on 14th Oct 2020

Registration expiry Date

14th Oct 2030

Correspondent Address

LISA D. STATT FOY

(Field LLP)400 - 444 7 Avenue SWCALGARY

ALBERTA

CA

T2P0X8

ENTOURAGE

Trademark usage description

medicinal products for human use, namely pain relief medications, nausea treatment medications, antiinflammatory medicines, antispasmodic medications, Read More

Classification Information

Class [005]
Medicinal products for human use, namely pain relief medications, nausea treatment medications, antiinflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Medicines for dental use, namely pain relief medications, anti-inflammatory medicines, antispasmodic medications, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections; Veterinary medications, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, anticonvulsant (antiseizure) medicines; Medications administered in subcutaneous implant, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Biological preparations for medicine use, namely pain relief medications, nausea treatment medications, antiinflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Biological preparations for veterinary use, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, anticonvulsant (antiseizure) medicines; Bacterial preparations for medical and veterinary use, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Bacteriological preparations for medical and veterinary use, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Serum based medications, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Depurative medications, namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, appetite regulation and suppressant medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals, medicines for the treatment of anxiety, epilepsy, psychiatric disorders namely mood disorders, schizophrenia, cognitive and bipolar disorders, and cerebral palsy, neurodegenerative diseases, Alzheimer's, Parkinson's, Crohn's disease, HIV/AIDS, Post-Traumatic Stress Disorder (PTSD), and multiple sclerosis, anticonvulsant (antiseizure) medicines, antipsychotic medicines, antioxidant medicines, neuroprotector medicines, immunomodulatory medicines, and sleep medications; Medicines that affect the uterus , namely pain relief medications, nausea treatment medications, anti-inflammatory medicines, antispasmodic medications, palliative treatment for cancer symptoms and symptoms derived from chemotherapy and radiotherapy, medicines for enhancing the absorption of active ingredients, medicines for increasing resistance to bacterial infections, medicines for minimizing adverse side effects of medical conditions and pharmaceuticals

Classification kind code

10

Class [010]
Surgical instruments; Medical instruments; dental instruments

Classification kind code

10

Class [042]
Chemical analysis; Bacteriological research; Biological research; Chemical research; Advisory, consultancy and information about product development; Advisory, consultancy and information about scientific research in the field of biochemistry and biotechnology; Advisory, consultancy and information and research in the biological field; Advisory, consultancy and information on research in the biological field; Medical research; Scientific research namely pharmaceutical research

Classification kind code

10

Mark Details

Serial Number

1747294

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 15
on 8th Feb 2019		Correspondence Created
Submitted for opposition 12
on 24th Jul 2018		Extension of Time
Submitted for opposition 15
on 8th Jan 2018		Correspondence Created
Submitted for opposition 15
on 5th Jun 2017		Correspondence Created
Submitted for opposition 12
on 2th Sept 2016		Extension of Time
Submitted for opposition 22
on 2th Mar 2016		Search Recorded
Submitted for opposition 20
on 2th Mar 2016		Examiner's First Report
Submitted for opposition 31
on 25th Sept 2015		Formalized
Submitted for opposition 30
on 23rd Sept 2015		Filed
Submitted for opposition 1
on 23rd Sept 2015		Created